News UK ministers seek a soft Brexit for pharma Health and business secretaries commit to close working with EMA
News AZ sells migraine drug rights to Grunenthal for $300m AZ says migraine outside its strategic focus.
News Lynparza first PARP drug to show promise in breast cancer Data sets AZ up to file Lynparza in new indication
News AZ highlights data from next-gen oncology drugs at ASCO Tesara and Takeda among other companies to publish data.
News AZ’s Bydureon disappoints in diabetes outcomes trial Results give advantage to Boehringer/Lilly's Jardiance.
R&D The long-delayed promise of the microbiome, with Sam Possemi... Sam Possemiers, CEO of MRM Health, believes that the microbiome space is finally coming into maturity.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
